Atlas Trials

Multiple Treatment Session Study to Assess GSK2398852 Administered Following and Along With GSK2315698

Clinical trial NCT03044353 · TERMINATED

Trial details

NCT number
NCT03044353
Sponsor
GlaxoSmithKline
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Amyloidosis
Start date
2017-07-10
Primary completion
2019-01-03
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.